Influenza
-
healthConjugate Vaccine Technology Accelerates Influenza Antibody Response
Preclinical study shows conjugate vaccine platform iBoost enhances speed, strength, and diversity of antibody responses against influenza viruses.
-
healthEurope Approves Moderna's First mRNA Flu-COVID Vaccine, mCOMBRIAX
Moderna's mCOMBRIAX, the world's first mRNA combo vaccine for flu and COVID-19, receives European authorization, offering a simplified immunization option.
-
healthCanada Sees Surge in Respiratory Hospitalizations Amid Declining Vaccine Rates
Thousands hospitalized for COVID-19, flu, and RSV in Canada. Experts urge increased vaccination to ease strain on healthcare systems.
-
healthDisease Season Forecastability: Some Are Harder to Predict
New research reveals infectious disease forecasting difficulty varies by season, pathogen, and population size, impacting hospital admission predictions.
-
healthStanford Nasal Spray Vaccine Shows Promise for Multi-Disease Protection
A groundbreaking nasal spray vaccine developed at Stanford Medicine could offer simultaneous protection against COVID-19, flu, and pneumonia, potentially transforming respiratory illness prevention.
-
healthFlu Season Extended: Doctors Warn of Lingering Virus and Second Wave
US health experts caution that the current flu season may extend into spring, with a surge in influenza B cases following an aggressive influenza A.
-
healthSingle Vaccine Targets Flu and COVID-19, Shows Promising Results
New multicomponent mRNA vaccine demonstrates safety and robust immune response against influenza and COVID-19 in early trials.
-
healthChildhood Sleep Apnea Linked to Higher Viral Infection Risk
New research reveals children with obstructive sleep apnea face a significantly increased risk of influenza and COVID-19 diagnoses, even after common treatments.